BIOMERIEUX

Lobbying for BIOMERIEUX · Medical diagnostics

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Utah · House · Senate · $160,000.00 expenses · posted Jul 20, 2026

Lobbying activity 4

Tariff (miscellaneous tariff bills)

Discussions regarding tariff proposals

Budget/Appropriations

Discussions regarding Veterans Affairs Appropriations Discussions regarding Indian Health Services Appropriations

Health Issues

Issues regarding womens health Equitable Community Access to Pharmacists Services Act

Medical/Disease Research/Clinical Labs

Discussions regarding PASTEUR Act, the RESULTS Act, CLIA Modernization, and antimicrobial resistance.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.